These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23953706)

  • 21. Evaluation of the modified FINDRISC to identify individuals at high risk for diabetes among middle-aged white and black ARIC study participants.
    Kulkarni M; Foraker RE; McNeill AM; Girman C; Golden SH; Rosamond WD; Duncan B; Schmidt MI; Tuomilehto J
    Diabetes Obes Metab; 2017 Sep; 19(9):1260-1266. PubMed ID: 28321981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece.
    Makrilakis K; Liatis S; Grammatikou S; Perrea D; Stathi C; Tsiligros P; Katsilambros N
    Diabetes Metab; 2011 Apr; 37(2):144-51. PubMed ID: 21144787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. External validation of Finnish diabetes risk score (FINDRISC) and Latin American FINDRISC for screening of undiagnosed dysglycemia: Analysis in a Peruvian hospital health care workers sample.
    Yovera-Aldana M; Mezones-Holguín E; Agüero-Zamora R; Damas-Casani L; Uriol-Llanos B; Espinoza-Morales F; Soto-Becerra P; Ticse-Aguirre R
    PLoS One; 2024; 19(8):e0299674. PubMed ID: 39110713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-invasive Risk Prediction Models in Identifying Undiagnosed Type 2 Diabetes or Predicting Future Incident Cases in the Iranian Population.
    Lotfaliany M; Hadaegh F; Asgari S; Mansournia MA; Azizi F; Oldenburg B; Khalili D
    Arch Iran Med; 2019 Mar; 22(3):116-124. PubMed ID: 31029067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of screening questionnaires and risk scores for undiagnosed diabetes: the KORA Survey 2000.
    Rathmann W; Martin S; Haastert B; Icks A; Holle R; Löwel H; Giani G;
    Arch Intern Med; 2005 Feb; 165(4):436-41. PubMed ID: 15738374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Shifting from glucose diagnosis to the new HbA1c diagnosis reduces the capability of the Finnish Diabetes Risk Score (FINDRISC) to screen for glucose abnormalities within a real-life primary healthcare preventive strategy.
    Costa B; Barrio F; Piñol JL; Cabré JJ; Mundet X; Sagarra R; Salas-Salvadó J; Solà-Morales O;
    BMC Med; 2013 Feb; 11():45. PubMed ID: 23438147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skin autofluorescence improves the Finnish Diabetes Risk Score in the detection of diabetes in a large population-based cohort: The LifeLines Cohort Study.
    Fokkens BT; van Waateringe RP; Mulder DJ; Wolffenbuttel BHR; Smit AJ
    Diabetes Metab; 2018 Nov; 44(5):424-430. PubMed ID: 29097003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Finnish Diabetes Risk Score (FINDRISC) as a screening tool for hepatic steatosis.
    Carvalho JA; Barengo NC; Tuomilehto J; Conceição RD; Santos RD
    Ann Med; 2011; 43(6):487-94. PubMed ID: 21604917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FINDRISC Modified for Latin America as a Screening Tool for Persons with Impaired Glucose Metabolism in Ciudad Bolívar, Venezuela.
    Muñoz-González MC; Lima-Martínez MM; Nava A; Trerotola G; Paoli M; Cabrera-Rego JO; Gonzalez B; Arciniegas A; Paez J
    Med Princ Pract; 2019; 28(4):324-332. PubMed ID: 30852570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the Finnish Diabetes Risk Score as a screening tool for impaired fasting glucose, impaired glucose tolerance and undetected diabetes.
    Tankova T; Chakarova N; Atanassova I; Dakovska L
    Diabetes Res Clin Pract; 2011 Apr; 92(1):46-52. PubMed ID: 21242013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between the Finnish Diabetes Risk Score (FINDRISC), vitamin D levels, and insulin resistance in obese subjects.
    Lima-Martínez MM; Arrau C; Jerez S; Paoli M; González-Rivas JP; Nieto-Martínez R; Iacobellis G
    Prim Care Diabetes; 2017 Feb; 11(1):94-100. PubMed ID: 27914905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early detection of type 2 diabetes in socioeconomically disadvantaged areas in Stockholm - comparing reach of community and facility-based screening.
    Timm L; Harcke K; Karlsson I; Sidney Annerstedt K; Alvesson HM; Stattin NS; Forsberg BC; Östenson CG; Daivadanam M
    Glob Health Action; 2020 Dec; 13(1):1795439. PubMed ID: 32746747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A simplified Finnish diabetes risk score to predict type 2 diabetes risk and disease evolution in a German population.
    Bergmann A; Li J; Wang L; Schulze J; Bornstein SR; Schwarz PE
    Horm Metab Res; 2007 Sep; 39(9):677-82. PubMed ID: 17846976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a screening score for undiagnosed diabetes and its application in estimating absolute risk of future type 2 diabetes in Japan: Toranomon Hospital Health Management Center Study 10 (TOPICS 10).
    Heianza Y; Arase Y; Saito K; Hsieh SD; Tsuji H; Kodama S; Tanaka S; Ohashi Y; Shimano H; Yamada N; Hara S; Sone H
    J Clin Endocrinol Metab; 2013 Mar; 98(3):1051-60. PubMed ID: 23393174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the Finnish Diabetes Risk Score Model With the Metabolic Syndrome in a Shanghai Population.
    Jin S; Chen Q; Han X; Liu Y; Cai M; Yao Z; Lu H
    Front Endocrinol (Lausanne); 2022; 13():725314. PubMed ID: 35273562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of two screening methods for undiagnosed diabetes in China: an cost-effectiveness study.
    Zhang Y; Sun J; Pang Z; Gao W; Sintonen H; Kapur A; Qiao Q
    Prim Care Diabetes; 2013 Dec; 7(4):275-82. PubMed ID: 24021478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Undetected dysglycaemia common in primary care patients treated for hypertension and/or dyslipidaemia: on the need for a screening strategy in clinical practice. A report from EUROASPIRE IV a registry from the EuroObservational Research Programme of the European Society of Cardiology.
    Shahim B; Gyberg V; De Bacquer D; Kotseva K; De Backer G; Schnell O; Tuomilehto J; Wood D; Rydén L
    Cardiovasc Diabetol; 2018 Jan; 17(1):21. PubMed ID: 29368616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis of erectile dysfunction can be used to improve screening for Type 2 diabetes mellitus.
    Carrillo-Larco RM; Luza-Dueñas AC; Urdániga-Hung M; Bernabé-Ortiz A
    Diabet Med; 2018 Nov; 35(11):1538-1543. PubMed ID: 30028534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Establishing a noninvasive prediction model for type 2 diabetes mellitus based on a rural Chinese population].
    Zhang HY; Shi WH; Zhang M; Yin L; Pang C; Feng TP; Zhang L; Ren YC; Wang BY; Yang XY; Zhou JM; Han CY; Zhao Y; Zhao JZ; Hu DS
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 May; 50(5):397-403. PubMed ID: 27141894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening of undiagnosed hyperglycaemia in the dental setting: The DiabetRisk study. A field trial.
    Montero E; Matesanz P; Nobili A; Luis Herrera-Pombo J; Sanz M; Guerrero A; Bujaldón A; Herrera D;
    J Clin Periodontol; 2021 Mar; 48(3):378-388. PubMed ID: 33263197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.